Home/Filings/4/0000950170-23-066155
4//SEC Filing

SMISEK JEFFERY A 4

Accession 0000950170-23-066155

CIK 0001733257other

Filed

Nov 26, 7:00 PM ET

Accepted

Nov 27, 4:54 PM ET

Size

7.0 KB

Accession

0000950170-23-066155

Insider Transaction Report

Form 4
Period: 2023-11-22
Transactions
  • Sale

    Common Stock

    2023-11-22$3.64/sh1,470$5,3516,642 total
Holdings
  • Common Stock

    (indirect: See footnote)
    40,260
  • Common Stock

    (indirect: By Spouse)
    8,112
Footnotes (4)
  • [F1]Represents the weighted-average price of shares sold by the broker on behalf of the Reporting Person. The broker sold, in the aggregate on behalf of such Reporting Person, 1,470 shares in transactions ranging from $3.63 to $3.67 with a weighted-average price of $3.64. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  • [F2]Includes shares previously held indirectly by Flight Partners Management LLC ("Flight Partners Capital") and are now held directly. The Reporting Person is the president of Flight Partners Capital.
  • [F3]The securities are held by Flight Partners Capital.
  • [F4]Includes shares previously held indirectly by Flight Partners Capital and are now held by the Reporting Person's spouse.

Documents

1 file

Issuer

Finch Therapeutics Group, Inc.

CIK 0001733257

Entity typeother

Related Parties

1
  • filerCIK 0001193038

Filing Metadata

Form type
4
Filed
Nov 26, 7:00 PM ET
Accepted
Nov 27, 4:54 PM ET
Size
7.0 KB